Workflow
Lineage Cell Therapeutics (NYSEAM:LCTX) FY Conference Transcript

Lineage Cell Therapeutics (NYSEAM:LCTX) FY Conference September 08, 2025 11:30 AM ET Company ParticipantsBrian Culley - CEO & DirectorSara Nik - VP & Equity Research - BiotechSara NikEveryone, and welcome to our next session. I'll be your moderator, Sarah Nick, an Equity Research VP at HC Wainwright, and it's my pleasure to introduce our next presenter, Brian Culley, CEO of Lineage Cell Therapeutics, a clinical-stage biotechnology company developing novel cell therapies for neurological and ophthalmic condi ...